These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 26432923)

  • 21. Intratracheal administration of activated protein C inhibits bleomycin-induced lung fibrosis in the mouse.
    Yasui H; Gabazza EC; Tamaki S; Kobayashi T; Hataji O; Yuda H; Shimizu S; Suzuki K; Adachi Y; Taguchi O
    Am J Respir Crit Care Med; 2001 Jun; 163(7):1660-8. PubMed ID: 11401891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects of andrographolide on the concentration of cytokines in BALF and the expressions of type I and III collagen mRNA in lung tissue in bleomycin-induced rat pulmonary fibrosis].
    Zhu HL; Huang CL; Wang WJ; Zhan XQ; Fan XM
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jul; 27(7):725-9. PubMed ID: 21722520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reversal of bleomycin-induced rat pulmonary fibrosis by a xenograft of human umbilical mesenchymal stem cells from Wharton's jelly.
    Chu KA; Wang SY; Yeh CC; Fu TW; Fu YY; Ko TL; Chiu MM; Chen TH; Tsai PJ; Fu YS
    Theranostics; 2019; 9(22):6646-6664. PubMed ID: 31588241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Anti-type IV collagenase single-chain antibody ameliorates bleomycin-induced experimental pulmonary fibrosis in mice].
    Lai RY; Miao QF; Li Y; Zhen YS
    Zhonghua Yi Xue Za Zhi; 2009 May; 89(20):1411-5. PubMed ID: 19671337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metformin Reduces Bleomycin-induced Pulmonary Fibrosis in Mice.
    Choi SM; Jang AH; Kim H; Lee KH; Kim YW
    J Korean Med Sci; 2016 Sep; 31(9):1419-25. PubMed ID: 27510385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncostatin M-Preconditioned Mesenchymal Stem Cells Alleviate Bleomycin-Induced Pulmonary Fibrosis Through Paracrine Effects of the Hepatocyte Growth Factor.
    Lan YW; Theng SM; Huang TT; Choo KB; Chen CM; Kuo HP; Chong KY
    Stem Cells Transl Med; 2017 Mar; 6(3):1006-1017. PubMed ID: 28297588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bleomycin-induced pulmonary fibrosis is independent of eosinophils.
    Hao H; Cohen DA; Jennings CD; Bryson JS; Kaplan AM
    J Leukoc Biol; 2000 Oct; 68(4):515-21. PubMed ID: 11037973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The effect of marrow mesenchymal stem cell transplantation on pulmonary fibrosis in rats].
    Huang K; Wu XM; Wang XY; Kang XW; Xiao JL; Li ZG; Lu P
    Zhonghua Jie He He Hu Xi Za Zhi; 2012 Sep; 35(9):659-64. PubMed ID: 23158067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucagon like peptide-1 attenuates bleomycin-induced pulmonary fibrosis, involving the inactivation of NF-κB in mice.
    Gou S; Zhu T; Wang W; Xiao M; Wang XC; Chen ZH
    Int Immunopharmacol; 2014 Oct; 22(2):498-504. PubMed ID: 25111852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic effect of human umbilical cord mesenchymal stem cells modified by angiotensin-converting enzyme 2 gene on bleomycin-induced lung fibrosis injury.
    Min F; Gao F; Li Q; Liu Z
    Mol Med Rep; 2015 Apr; 11(4):2387-96. PubMed ID: 25435005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adipose-derived mesenchymal stem cell therapy for reverse bleomycin-induced experimental pulmonary fibrosis.
    Zhao X; Wu J; Yuan R; Li Y; Yang Q; Wu B; Zhai X; Wang J; Magalon J; Sabatier F; Daumas A; Zhu WM; Zhu N
    Sci Rep; 2023 Aug; 13(1):13183. PubMed ID: 37580529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conversion of bone marrow mesenchymal stem cells into type II alveolar epithelial cells reduces pulmonary fibrosis by decreasing oxidative stress in rats.
    Huang K; Kang X; Wang X; Wu S; Xiao J; Li Z; Wu X; Zhang W
    Mol Med Rep; 2015 Mar; 11(3):1685-92. PubMed ID: 25411925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Human placental mesenchymal stem cells of fetal origin relieves mouse pulmonary fibrosis via downregulating MyD88 and TGF-β signaling pathway].
    Tao J; Li Q; Ma X; Han F; Liu X; Wei J; Zhu Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Oct; 32(10):1347-1351. PubMed ID: 27667460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epicatechin protective effects on bleomycin-induced pulmonary oxidative stress and fibrosis in mice.
    Shariati S; Kalantar H; Pashmforoosh M; Mansouri E; Khodayar MJ
    Biomed Pharmacother; 2019 Jun; 114():108776. PubMed ID: 30903918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute pulmonary toxicity of bleomycin: DNA scission and matrix protein mRNA levels in bleomycin-sensitive and -resistant strains of mice.
    Harrison JH; Hoyt DG; Lazo JS
    Mol Pharmacol; 1989 Aug; 36(2):231-8. PubMed ID: 2475758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human bone marrow-derived mesenchymal stromal cells cultured in serum-free media demonstrate enhanced antifibrotic abilities via prolonged survival and robust regulatory T cell induction in murine bleomycin-induced pulmonary fibrosis.
    Takao S; Nakashima T; Masuda T; Namba M; Sakamoto S; Yamaguchi K; Horimasu Y; Miyamoto S; Iwamoto H; Fujitaka K; Hamada H; Takahashi S; Nakashima A; Hattori N
    Stem Cell Res Ther; 2021 Sep; 12(1):506. PubMed ID: 34530920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induced Pluripotent Stem Cells Inhibit Bleomycin-Induced Pulmonary Fibrosis in Mice through Suppressing TGF-β1/Smad-Mediated Epithelial to Mesenchymal Transition.
    Zhou Y; He Z; Gao Y; Zheng R; Zhang X; Zhao L; Tan M
    Front Pharmacol; 2016; 7():430. PubMed ID: 27895584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The exacerbating roles of CCAAT/enhancer-binding protein homologous protein (CHOP) in the development of bleomycin-induced pulmonary fibrosis and the preventive effects of tauroursodeoxycholic acid (TUDCA) against pulmonary fibrosis in mice.
    Tanaka Y; Ishitsuka Y; Hayasaka M; Yamada Y; Miyata K; Endo M; Kondo Y; Moriuchi H; Irikura M; Tanaka K; Mizushima T; Oike Y; Irie T
    Pharmacol Res; 2015 Sep; 99():52-62. PubMed ID: 26005208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resolution of bleomycin-induced murine pulmonary fibrosis via a splenic lymphocyte subpopulation.
    Kamio K; Azuma A; Matsuda K; Usuki J; Inomata M; Morinaga A; Kashiwada T; Nishijima N; Itakura S; Kokuho N; Atsumi K; Hayashi H; Yamaguchi T; Fujita K; Saito Y; Abe S; Kubota K; Gemma A
    Respir Res; 2018 Apr; 19(1):71. PubMed ID: 29690905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NMDA receptor activation inhibits the antifibrotic effect of BM-MSCs on bleomycin-induced pulmonary fibrosis.
    Li X; Li C; Tang Y; Huang Y; Cheng Q; Huang X; Zhao F; Hao C; Feng D; Xu J; Han J; Tang S; Liu W; Yue S; Luo Z
    Am J Physiol Lung Cell Mol Physiol; 2018 Sep; 315(3):L404-L421. PubMed ID: 29722562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.